Casdin Capital LLC 13D/13G Filings for Verve Therapeutics, Inc. (VERV)

Casdin Capital LLC 13D and 13G filings for Verve Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2023-02-13
9:27 pm
Sale		2022-12-3113GVerve Therapeutics, Inc.
VERV		Casdin Capital LLC2,290,571
3.700%		-847,596decrease
(-27.01%)		Filing
2022-02-14
09:27 am
Purchase		2021-12-3113GVerve Therapeutics, Inc.
VERV		Casdin Capital LLC3,138,167
6.500%		100,000increase
(+3.29%)		Filing
2021-06-23
11:38 am
Purchase		2021-06-1713GVerve Therapeutics, Inc.
VERV		Casdin Capital LLC3,038,167
6.600%		3,038,167increase
(New Position)		Filing